Weight management in primary care
|
|
- Curtis Wilkinson
- 5 years ago
- Views:
Transcription
1 Weight management in primary care Professor Susan Jebb Nuffield Department of Primary Care Health Sciences University of Oxford Declaration: Funding for some of the interventions in this presentation has been provided by weight management companies. I receive no personal renumeration from any private company.
2
3 How effective are interventions suitable for use in routine care with non-specialist staff and realistic NHS resources? Meta-analysis for NICE PH53 Intervention vs minimal contact control (BOCF): kg (95% CI: -3.61, -2.07); p < Hartmann-Boyce, Johns, Jebb, Summerbell, Aveyard. Obes Rev (11): Intervention Control Mean Difference Mean Difference Study or Subgroup Appel 2011 (in person) Appel 2011 (phone) Bertz 2012 Dale 2008 (intense) Dale 2008 (modest) DPP 2002 Eriksson 2009 Fitzgibbon 2010 Foster-Schubert 2012 Hersey 2012 (arm 2) Hersey 2012 (arm 3) Heshka 2003 Jebb 2011 Jolly 2011 (GP) Jolly 2011 (pharmacist) Jolly 2011 (RC) Jolly 2011 (SD) Jolly 2011 (SW) Jolly 2011 (WW) Kuller 2012 Lindstrom 2003 Mensink 2003 Morgan 2011 Munsch 2003 (clinic) Munsch 2003 (GP) Nanchahal 2011 Patrick 2011 Penn 2009 Rejeski 2011 Rock 2010 (in person) Rock 2010 (phone) Ross 2012 Silva 2010 Stevens 1993 Stevens 2001 Vermunt 2011 Villareal 2011 Vissers 2010 (fitness) Vissers 2010 (vibration) Wadden 2011 Total (95% CI) Mean SD Total Mean SD Total Weight 2.6% 2.6% 1.6% 1.4% 1.6% 3.0% 2.6% 2.7% 2.8% 2.2% 2.2% 2.2% 2.2% 2.2% 2.2% 2.8% 2.8% 2.3% 2.2% 2.2% 2.8% 2.7% 2.4% 2.5% 2.5% 2.8% 2.5% 1.9% 1.8% 2.7% 100.0% IV, Random, 95% CI [-5.57, -2.23] [-5.87, -2.53] [-10.71, -2.49] 3.60 [-1.01, 8.21] 4.10 [-0.01, 8.21] [-6.65, -5.55] [-1.45, 0.25] [-4.09, -0.75] [-9.59, -6.81] [-1.37, -0.03] [-1.28, 0.08] [-4.12, -1.88] [-3.00, -1.58] 0.30 [-2.47, 3.07] 0.40 [-2.31, 3.11] [-3.73, 1.73] [-4.09, 1.29] [-3.42, 1.82] [-5.18, 0.38] [-6.18, -4.02] [-4.05, -2.55] [-3.27, -0.83] [-4.46, 0.26] [-3.35, 1.95] [-6.16, -0.64] [-1.18, 0.58] [-1.96, 0.56] [-3.51, -0.69] [-7.61, -3.39] [-9.57, -5.63] [-8.05, -3.95] [-2.19, -0.21] [-5.55, -3.29] [-5.48, -3.52] [-3.12, -1.68] [-0.82, 0.42] [-9.84, -5.76] [-10.85, -3.95] [-11.99, -4.61] [-2.35, 0.75] [-3.61, -2.07] IV, Random, 95% CI Heterogeneity: Tau² = 5.12; Chi² = , df = 39 (P < ); I² = 93% Test for overall effect: Z = 7.25 (P < ) Favours intervention Favours control
4 Effectiveness of treatment in primary care or in community weight loss groups Primary care vs control: kg (95% CI: -0.87, 0.44); p = 0.52 Community weight-loss groups vs control: kg (95% CI: -2.81, -1.73); p< Hartmann-Boyce, Johns, Jebb, Summerbell, Aveyard. Obes Rev Nov;15(11):
5 Weight(kg) Primary care referral to a commercial provider significantly increases weight loss: BOCF WW SC kg p < kg Time (months) Jebb et al Lancet. 2011;378(9801):
6 The WRAP trial: Weight-loss Referrals for Adults in Primary care (n = 1267, 23 practices) Aims To evaluate the clinical and cost effectiveness of three weight loss interventions that can be delivered in primary care: CP52; referral to a commercial provider for 52 weeks (approx 200) CP12; referral for 12 weeks (approx 50) BI; a brief intervention (approx 7) Participants 68% female, Mean age = 53 Mean BMI = 34.5 HbA1c = 42 mmol/mol Ahern, Aveyard, Halford, Mander, Cresswell, Cohn, Suhrcke, Marsh, Thomson, Jebb. BMC Public Health Jun 18;14:62
7 Weight change over 1y BI CP12 CP52 CP vs BI CP52 vs CP12 MAR * (-3.53, -0.89) -2.65* (-3.99, -1.32)
8 Change in cardiovascular risk factors Mean (SE) Change Adj Difference (95%CI) BI CP12 CP52 CP52vs BI CP52vsCP12 Glucose (mmol/l) (0.20) (0.10) (0.08) -0.46* (-0.88,-0.03) -0.29* (-0.58, ) HbA1c (mmol/mol) 0.15 (0.69) (0.37) (0.47) -2.65** (-4.28, -1.01) -1.31* (-2.47,-0.15) Triglycerides (mmol/l) (0.07) (0.05) (0.03) (-0.25, 0.07) (-0.14, 0.09) Cholesterol (mmol/l) (0.10) (0.05) (0.05) (-0.24, 0.14) (-0.17, 0.09) HDL Cholesterol 0.01 (0.10) 0.02 (0.05) 0.02 (0.05) 0.00 (-0.19, 0.19) 0.00 (-0.13, 0.14) LDL Cholesterol (0.04) (0.03) (0.03) 0.01 (-0.12, 0.13) (-0.11, 0.07)
9 Weight change over 2 years BI CP12 CP No. Participants Primary Analysis Weight change Month Standard error bars shown around mean estimates BI CP12 CP52
10 % Opportunistic interventions for weight management: how do patients feel? N = Appropriate Helpful Very unhelpful Unhelpful Neither helpful or unhelpful Helpful Very unhelpful Aveyard et al. Lancet Oct 21. pii: S (16)
11 77% of patients accepted the referral Aveyard et al. Lancet Oct 21. pii: S (16)
12 More than half attended the programme No booking Did not attend Start but not complete course Complete course Aveyard et al. Lancet Oct 21. pii: S (16)
13 Opportunistic interventions can increase weight lost at 1 y 0 Control Weight change at 12 months Intervention (95%CI -1.97; -0.89), p< Aveyard et al. Lancet Oct 21. pii: S (16)
14 Very low energy diets enhance weight loss at 1 y VLED vs BWMP: kg (95% CI: -7.41, -1.14); p < Parretti, Jebb, Johns, Lewis, Christian and Aveyard, Obes Rev Jan 18. doi: /obr
15 Weight regain in BWMP over extended followup (BOCF analysis) NICE reviiew
16 Diabetes Prevention Programme: Sustained reductions in diabetes incidence - despite weight regain DPP. Lancet, 14 (2009), pp
17 Weight management in primary care Brief advice from a doctor to encourage weight loss is acceptable can motivate effective action More than a third of patients lose at least 5% initial weight following referral to a commercial weight loss group Increased duration of support significantly increases health benefits Very low energy formula diets lead to greater weight loss but, as yet, are rarely used in routine settings Weight regain is common but does not invalidate the benefits of initial losses Size matters: need to scale-up to achieve population-level impact A brief intervention, resulting in 1.5 kg weight loss, delivered once a year to all eligible people visiting their GP, could halve the prevalence of obesity by 2035
18 Nuffield Department of Primary Care Health Scie Presentation title, edit in header and footer (view menu) January 24, 2017 Page 19
What could a public health strategy for weight loss look like? Paul Aveyard Professor of behavioural medicine
What could a public health strategy for weight loss look like? Paul Aveyard Professor of behavioural medicine Conflicts of interest In this research and in other similar research, commercial weight loss
More informationKaren Miller-Kovach
04.12.12 Karen Miller-Kovach MBA, MS, RD, Chief Scientific Officer, Weight Watchers International, Inc. When left to lose weight on their own, most people do not succeed. 433 Participants; mean age 45
More informationReferral to a commercial weight management programme enhances weight loss achieved in primary care
Referral to a commercial weight management programme enhances weight loss achieved in primary care Susan A. Jebb, Amy L. Ahern, Ashley D. Olson, Louise M. Aston - MRC Human Nutrition Research Unit, Cambridge,
More informationDoctor Referral of Overweight People to Low Energy total diet replacement Treatment (DROPLET): pragmatic randomised controlled trial
Nuffield Department of Primary Care Health Sciences, University of Oxford, UK Correspondence to: NM Astbury nerys.astbury@phc.ox.ac.uk Additional material is published online only. To view please visit
More informationOverview of Glasgow & Clyde Weight Management Service (GCWMS) Gillian Bryson. Specialist Dietitian/ Clyde team lead
Overview of Glasgow & Clyde Weight Management Service (GCWMS) Gillian Bryson Specialist Dietitian/ Clyde team lead Main areas requested to cover Referral process What occurs at the service What the patient
More informationPrimary Outcome Results of DiRECT the Diabetes REmission Clinical Trial
Finding a practical management solution for T2DM, in primary care Primary Outcome Results of DiRECT the Diabetes REmission Clinical Trial Mike Lean, Roy Taylor, and the DiRECT Team IDF Abu Dhabi, December
More informationWhite Rose Research Online URL for this paper:
This is an author produced version of Weight loss referrals for adults in primary care (WRAP) : Protocol for a multi-centre randomised controlled trial comparing the clinical and cost-effectiveness of
More informationReducing the prevalence of obesity one consultation at a time. Paul Aveyard Professor of behavioural medicine
Reducing the prevalence of obesity one consultation at a time Paul Aveyard Professor of behavioural medicine Conflicts of interest In this research and in other similar research, commercial weight loss
More informationOpportunistic health promotion
Opportunistic health promotion (or how do I tell my pa1ent they are fat? ) Dr KE Leedham-Green Department of Primary Care and Public Health Sciences, KUMEC A quick survey Hold your hand to your chest and
More informationLet s Talk About Weight: A step-by-step guide to brief interventions with adults for health and care professionals
: A step-by-step guide to brief interventions with adults for health and care professionals About Public Health England Public Health England exists to protect and improve the nation s health and wellbeing,
More informationTreating obesity and excess weight using a holistic, Pharmacy based approach to weight management.
Waistaway Study 2016 Gareth Evans MRParmS Treating obesity and excess weight using a holistic, Pharmacy based approach to weight management. Abstract The aim of our Waistaway¹ Pharmacy service is to help
More informationType 2 diabetes how to prevent it? East of England Diabetes Mellitus Transformation and Sustainability Network 28 th March 2018
Type 2 diabetes how to prevent it? East of England Diabetes Mellitus Transformation and Sustainability Network 28 th March 2018 Dr Charles Bodmer Consultant Clinical Lead Dr Sonica Goel GP Clinical Lead
More informationDiabetes Passport. East Coast Area Diabetes Integrated Care
Diabetes Passport East Coast Area Diabetes Integrated Care Personal Details Name: Address: Developed by East Coast Area Diabetes Programme (ECAD), 2014. Thanks to Beaumont Hospital for allowing us to use
More informationNHS NATIONAL DIABETES PREVENTION PROGRAMME. Tom Newbound, NHS DPP Programme Manager
NHS NATIONAL DIABETES PREVENTION PROGRAMME Tom Newbound, NHS DPP Programme Manager Site Focus Progress Birmingham Implement new service with new providers DPPs live 1 st November Bradford Bradford Beating
More informationInsulin pumps. Norman Waugh Warwick Medical School.
Insulin pumps Norman Waugh Warwick Medical School norman.waugh@warwick.ac.uk Insulin pumps Small device to support continuous subcutaneous insulin infusion Alternative to multiple daily injections (MDI)
More informationAssessing the economics of a stratified treatment approach for Type 2 Diabetes
Assessing the economics of a stratified treatment approach for Type 2 Diabetes A. Green 1, A. Gray 4, R. Holman 4, A. Farmer 4, N. Sattar 5, A. Jones 3, A. Hattersley 3, E. Pearson 2, C. Jennison 1, 1
More informationthe person is intolerant of either metformin or a sulphonylurea, or treatment with metformin or a sulphonylurea is contraindicated, and
Exenatide (Byetta) and Liraglutide (Victoza) prescribing guidance: Notes for initiation in primary care These incretin mimetics are given by subcutaneous injection once or twice daily. They have similar
More informationComparing the Cochrane review of electronic cigarettes to other meta-analyses
Comparing the Cochrane review of electronic cigarettes to other meta-analyses Jamie Hartmann-Boyce Cochrane Tobacco Addiction Group, Nuffield Department of Primary Care Health Sciences, University of Oxford.
More informationNon-insulin treatment in Type 1 DM Sang Yong Kim
Non-insulin treatment in Type 1 DM Sang Yong Kim Chosun University Hospital Conflict of interest disclosure None Committee of Scientific Affairs Committee of Scientific Affairs Insulin therapy is the mainstay
More informationDr Emma Solomon and Zoe Clifford
Evaluation of the Living Well, Taking Control Community-based Prevention and Management of Type 2 Diabetes Programme: a Study Protocol and Presentation of Preliminary Findings Dr Emma Solomon and Zoe Clifford
More informationCase study for CME Diabetes up-to-date management
Case study for CME Diabetes up-to-date management Dr Ole Schmiedel, MRCP MD FRACP Physician and Endocrinologist Service Clinical Director Auckland Diabetes Centre GP referral to Auckland Diabetes Centre
More informationPrimary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial
Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial Susan A Jebb, Amy L Ahern, Ashley D Olson, Louise M Aston, Christina Holzapfel,
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Primary prevention of CVD Potential output:
More informationObesity Prevention and Control: Provider Education with Patient Intervention
Obesity Prevention and : Provider Education with Patient Summary Evidence Table and Population Cohen et al. (1991) 1987-1988 : RCT Location: Pittsburgh, PA Physician training session by a behavioral psychologist
More informationPOTENTIAL LINKAGES BETWEEN THE QUALITY AND OUTCOMES FRAMEWORK (QOF) AND THE NHS HEALTH CHECK
POTENTIAL LINKAGES BETWEEN THE QUALITY AND OUTCOMES FRAMEWORK (QOF) AND THE NHS HEALTH CHECK Author: CHARLOTTE SIMPSON, SPECIALTY REGISTAR PUBLIC HEALTH (ST3), CHESHIRE EAST COUNCIL/MERSEY DEANERY SUMMARY
More informationPrimary Care Smoking Cessation. GP and Clinical Director WRPHO Primary Care Advisor MOH Tobacco Team Target Champion Primary Care Tobacco
Primary Care Smoking Cessation Dr John McMenamin GP and Clinical Director WRPHO Primary Care Advisor MOH Tobacco Team Target Champion Primary Care Tobacco Target or Tickbox? The Tobacco health target:
More informationPATIENT GROUP DIRECTION FOR THE SUPPLY OF ORLISTAT BY COMMUNITY PHARMACISTS
PATIENT GROUP DIRECTION FOR THE SUPPLY OF ORLISTAT BY COMMUNITY PHARMACISTS November 2009 Orlistat PGD Page 1 of 7 Rationale Patient Group Direction For Supply Of Orlistat By Community Pharmacists To enable
More informationLooking after your diabetic foot ulcer
Looking after your diabetic foot ulcer diabetes information and advice leaflet Emergency Action Plan FOOT ATTACK? If your foot is red, swollen or if you have skin breakdown RING 07786250788 IMMEDIATELY.
More informationORE Open Research Exeter
ORE Open Research Exeter TITLE Diabetes prevention in the real world: Effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline
More informationDoes metformin modify the effect on glycaemic control of aerobic exercise, resistance exercise or both?
Diabetologia (2013) 56:2378 2382 DOI 10.1007/s00125-013-3026-6 SHORT COMMUNICATION Does metformin modify the effect on glycaemic control of aerobic exercise, resistance exercise or both? Normand G. Boulé
More informationIntegrating Services To Achieve Better Outcomes In Obesity Management. Dr Nic Kormas FRACP
Integrating Services To Achieve Better Outcomes In Obesity Management Dr Nic Kormas FRACP Outline Why more resources needed to manage & prevent obesity induced co morbidities Case study demonstrating better
More informationPresenter: Lurline Less April 2018
Presenter: Lurline Less April 2018 1 DIABETES ASSOCIATION OF JAMAICA Non-profit, Non-governmental Organization, started In 1976, Incorporated In 1983 Work With Government And Private Sector Provide Primary
More informationprogramme. The DE-PLAN follow up.
What are the long term results and determinants of outcomes in primary health care diabetes prevention programme. The DE-PLAN follow up. Aleksandra Gilis-Januszewska, Noël C Barengo, Jaana Lindström, Ewa
More informationDelivery of An Evolving Well Established Community Diabetes Service in South Sefton
Delivery of An Evolving Well Established Community Diabetes Service in South Sefton Dr Nigel Taylor Clinical Lead for Diabetes South Sefton CCG Margaret Daley Lead Diabetes Specialist Nurse South Sefton
More informationNursing in Scotland. Glasgow & Clyde Weight Management Service
Nursing in Scotland Glasgow & Clyde Weight Management Service Contact: Dr Marie L Prince Chartered Clinical Psychologist marie.prince@ggc.scot.nhs.uk GCWMS Ward 23 Surgical Block Glasgow Royal Infirmary
More informationClinical Study Synopsis
Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace
More informationSurveillance report Published: 28 March 2018 nice.org.uk
Surveillance report 2018 Type 2 diabetes prevention: ention: population and community-level el interventions entions (2011) NICE guideline PH35 and Type 2 diabetes: prevention ention in people at high
More informationOne year outcomes of Type 2 Diabetes Mellitus Patients after an Integrated Patient Care Plan (IPCP) Presented by APN Ng Sau Yee NTW Diabetes Centre
One year outcomes of Type 2 Diabetes Mellitus Patients after an Integrated Patient Care Plan (IPCP) Presented by APN Ng Sau Yee NTW Diabetes Centre Background No endocrine team in NTWC before 2003 Great
More informationWest Midlands Familial Hypercholesterolaemia Service
Elaine George WMFHS Clinical Programme Manager West Midlands Familial Hypercholesterolaemia Service Elaine George WMFHS Clinical Programme Manager PCCS Conference November 2018 1 Presentation Objectives
More informationDiabetes Prevention programme
Diabetes Prevention programme Helen Booth Business Manager Naomi Jones Worcestershire Service Manager ICS Health & Wellbeing The ICS group Healthier You Healthier You: NHS Diabetes Prevention programme
More informationEfficacy/pharmacodynamics: 85 Safety: 89
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription. Sponsor/Company: Sanofi Drug substance:
More informationCommunity Based Diabetes Prevention
Community Based Diabetes Prevention Melanie Davies Professor of Diabetes Medicine Outline NIHR Programme Grant proposal and update to progress The Vascular Check programme HbA1c debate Algorithm to detect
More informationPortion size and weight control: Insights from new research and implications for policy and practice
Portion size and weight control: Insights from new research and implications for policy and practice Professor Susan Jebb Nuffield Department of Primary Care Health Sciences University of Oxford Increases
More informationNHS DIABETES PREVENTION PROGRAMME: Preventing Type 2 Diabetes in England
NHS DIABETES PREVENTION PROGRAMME: Preventing Type 2 Diabetes in England Who we are Public Health England (PHE) is an executive agency of the Department of Health. We protect and improve the nation's health
More informationIFST Lecture 2012 Prof. Colin Dennis CBE President, IFST
Kindly sponsored by: Drinks reception sponsored by: IFST Lecture 2012 Prof. Colin Dennis CBE President, IFST Kindly sponsored by: Drinks reception sponsored by: IFST Lecture 2012 Dr Susan Jebb OBE Head
More informationManaging my diabetes. a pictorial guide
Managing my diabetes a pictorial guide This booklet explains the steps to staying well with diabetes. It is intended to be used with the help of your health professionals. Diabetes WA is a member based
More informationBariatric Surgery Questionnaire
Bariatric Surgery Questionnaire This guidance applies to N.H.S. England only. This sheet is to assist you in researching your weight loss surgery options. The National Health Service uses a Tier system
More informationVascular Health. Health Program
Vascular Health Health Program Vascular Health program Designed for those with Peripheral Vascular Disease (PVD), the Vascular Health program puts you in charge of your health. Your personal Health Coach
More informationImplications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes?
Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes? Boston, MA November 7, 213 Edward S. Horton, MD Professor of Medicine Harvard Medical School Senior Investigator
More informationCase study: Adult with uncontrolled type 2 diabetes of long duration and cardiovascular disease
Case study: Adult with uncontrolled type 2 diabetes of long duration and cardiovascular disease Authored by Paul Zimmet and Richard Nesto on behalf of the Global Partnership for Effective Diabetes Management.
More informationIntegrated Community Diabetes Services (ICDS) GP Referral Guide Version 3 - October 2014
Integrated Community Diabetes Services (ICDS) GP Referral Guide Version 3 - October 2014 Introduction The Integrated Community Diabetes Service (ICDS) will deliver high quality care to individuals who
More informationDiagnostic criteria for diabetes Routine cases and Non-diabetic hyperglycaemia adapted with permission from Royal Devon and Exeter
Diagnostic criteria for diabetes Routine cases and Non-diabetic hyperglycaemia adapted with permission from Royal Devon and Exeter Diabetes may be diagnosed on any of the following criteria (WHO 2006,
More informationImplementing Type 2 Diabetes Prevention Programmes
Implementing Type 2 Diabetes Prevention Programmes Jaakko Tuomilehto Department of Public Health University of Helsinki Helsinki, Finland FIN-D2D Survey 2004 Prevalence of previously diagnosed and screen-detected
More informationLooking after your diabetic foot ulcer
Looking after your diabetic foot ulcer diabetes information and advice leaflet Emergency Action Plan FOOT ATTACK? If your foot is red, swollen or if you have breaks in the skin PHONE 07786250788 IMMEDIATELY.
More informationGetting Serious About CVD Prevention What does this mean for Primary Care?
Getting Serious About CVD Prevention What does this mean for Primary Care? Dr Matt Kearney GP and National Clinical Director for Cardiovascular Disease Prevention NHS England and Public Health England
More informationThis information is intended to be used with the help of a relevant health professional, and is available as a booklet to download.
Goals of management Goals of management is a guide to assist you in managing your diabetes. It is important when you have your health checks you have an understanding of what the numbers signify and how
More informationThe challenge of a 2-year follow-up after intervention for weight loss in primary care
International Journal of Obesity (2014) 38, 6 811 & 2014 Macmillan Publishers Limited All rights reserved 0307-0565/14 www.nature.com/ijo OPEN ORIGINAL ARTICLE The challenge of a 2-year follow-up after
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE General practice Indicators for the NICE menu
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE General practice Indicators for the NICE menu Indicator area: Pulse rhythm assessment for AF Indicator: NM146 Date: June 2017 Introduction There is evidence
More informationChanging Behaviour to Improve Population Health and Reduce Health Inequalities
Changing Behaviour to Improve Population Health and Reduce Health Inequalities Professor Theresa Marteau Behaviour and Health Research Unit University of Cambridge @BHRUCambridge @MarteauTM tm388@cam.ac.uk
More informationFigures recently published by THE NHS DIABETES PREVENTION PROGRAMME A PROGRESS REPORT FEATURE
Physical activity is a core goal in prevention of Type 2 diabetes THE NHS DIABETES PROGRAMME A PROGRESS REPORT Louise Ansari, Director of Prevention at Diabetes UK and member of the NHS Diabetes Prevention
More informationGuidelines to assist General Practitioners in the Management of Type 2 Diabetes. April 2010
Guidelines to assist General Practitioners in the Management of Type 2 Diabetes April 2010 Foreword The guidelines were devised by the Diabetes Day Centre in Beaumont Hospital in consultation with a number
More informationVascular checks a vascular risk assessment and management. Heather White Deputy Branch Head Vascular Programme
Vascular checks a vascular risk assessment and management Heather White Deputy Branch Head Vascular Programme Three Questions (1) What is the starting point? (2) Where are we now? (3) What happens next?
More informationStandard Operating Procedure 11. Completion of DAFNE Data Collection: Full Post Course Form F04.010, Version 8
Standard Operating Procedure 11 Completion of DAFNE Data Collection: Full Post Course Form F04.010, Version 8 Date Version Issue Review Contact Approved Date Date Person October 2013 9 October 2013 March
More informationDeprivation Study. The Freiburg Study
The Freiburg Study Deprivation Study Free Radicals Inflammation (hs-crp) Blood Pressure (Systolic, Diastolic) Blood Lipids (Cholesterol, Triglycerides) Energy Utilization (Heart Rate) Sugar Metabolism
More informationPractice Baseline Questionnaire/Practice development plan for Consultant/DSN meeting
Practice Baseline Questionnaire/Practice development plan for Consultant/DSN meeting Name of Practice Contact details of practice staff who you would like a copy of this questionnaire to be sent to when
More informationWellbeing at work update. Alison Rowntree Health Improvement Manager
Wellbeing at work update Alison Rowntree Health Improvement Manager What s new? A new wellbeing at work website is about to be launched NHS Health checks NHS Health Checks Aim to reduce the onset of heart
More informationPrediabetes: Metformin vs. Lifestyle Intervention Tannaz Moin, MD, MBA, MSHS
Prediabetes: Metformin vs. Lifestyle Intervention Tannaz Moin, MD, MBA, MSHS Assistant Professor, David Geffen School of Medicine at UCLA Division of Endocrinology, Diabetes and Metabolism HSR&D Center
More informationNHS England Impact Analysis of implementing NHS Diabetes Prevention Programme, 2016 to 2021
NHS England Impact Analysis of implementing NHS Diabetes Prevention Programme, 2016 to 2021 1. Purpose The purpose of this document is to describe both the estimated resource implications to NHS England
More informationDr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead
Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead Today s Presentation HbA1c & diagnosing Diabetes What is Impaired Glucose & IGR? Implications
More informationworking together for healthier communities
working together for healthier communities By Referral 14756 Brochure WW4314 v2.indd 1 09/02/2012 10:17 Just some of our successful members... INTRODUCTION & CONTENTS CONTENTS About Weight Watchers 2 How
More informationType 2 Diabetes. Stopping Smoking. Consider referral to smoking cessation. Consider referring for weight management advice.
Type 2 Diabetes Stopping Smoking Consider referral to smoking cessation BMI > 25 kg m² Set a weight loss target of a 5-10% reduction Consider referring for weight management advice Control BP to
More informationGetting serious about preventing cardiovascular disease
Getting serious about preventing cardiovascular disease Southwark s Experience Professor Kevin Fenton Director of Health and Wellbeing, London Borough of Southwark February 2018 Twitter: @ProfKevinFenton
More informationThe Role of the Diabetes Educator within the Patient-Centered Medical Home & Future Roles
The Role of the Diabetes Educator within the Patient-Centered Medical Home & Future Roles Linda M. Siminerio, RN, PhD, CDE Professor of Medicine University of Pittsburgh School of Medicine & Nursing Objectives
More informationSouthern Derbyshire Shared Care Pathology Guidelines. Dyslipidaemia
Southern Derbyshire Shared Care Pathology Guidelines Dyslipidaemia This guideline applies to patients with significantly abnormal lipid profiles, which may be primary (genetic), secondary to other diseases
More informationDelivering NDPP in a super diverse population
Delivering NDPP in a super diverse population Simon Doble, Senior Commissioning Manager BSC CCG Philomena Gales, NDPP Programme Manager NDPP Midlands & East Diabetes Regional Event 2 nd December 2016 Birmingham,
More informationPersonalized therapeutics in diabetes
Personalized therapeutics in diabetes Leen M. t Hart Molecular Cell Biology & Molecular Epidemiology Leiden University Medical Center Epidemiology & Biostatistics VU University Medical Center Diabetes
More informationManaging Overweight and Obesity among Adults. Report on Economic Modelling and Cost Consequence Analysis
Managing Overweight and Obesity among Adults Report on Economic Modelling and Cost Consequence Analysis Martin Brown, Tim Marsh, Lise Retat UK Health Forum Ric Fordham, Marc Suhrcke, David Turner, Richard
More informationInitial Weight Loss Consultation with your GP
Bariatric Surgery Questionnaire Initial Weight Loss Consultation with your GP This guidance applies to N.H.S. England only. This sheet is to assist you in researching your weight loss surgery options.
More informationSouth Bay Worksite Wellness. Health Coaching Report San Mateo County 2013 Health Coaching Program
South Bay Worksite Wellness Health Coaching Report Health Coaching Program Introduction Project Details Services were delivered to employees who are Kaiser Permanente members. Telephonic outreach was completed
More informationREGIONAL PHARMACY SPECIALIST SMOKING CESSATION SERVICE FEBRUARY A Pharmacist s Guide
REGIONAL PHARMACY SPECIALIST SMOKING CESSATION SERVICE FEBRUARY 2009 A Pharmacist s Guide Aims of the Service The overall aim of the service is to deliver a pharmacy based, one stop specialist smoking
More informationIn keeping with the Scottish Diabetes Group criteria, use should be restricted to those who:
Advice Statement 009-18 July 2018 Advice Statement What is the clinical and cost effectiveness of Freestyle Libre flash glucose monitoring for patients with diabetes mellitus treated with intensive insulin
More informationAlternative management of hypogonadism Tamoxifen. Emmanuele A. Jannini, MD Tor Vergata University of Rome ITALY
Alternative management of hypogonadism Tamoxifen Emmanuele A. Jannini, MD Tor Vergata University of Rome ITALY eajannini@gmail.com What hypogonadism is? What hypogonadism is? It is an empty glass The two
More informationFrequency of Dyslipidemia and IHD in IGT Patients
Frequency of Dyslipidemia and IHD in IGT Patients *Islam MS, 1 Hossain MZ, 2 Talukder SK, 3 Elahi MM, 4 Mondal RN 5 Impaired glucose tolerance (IGT) is often associated with macrovascular complications.
More informationCardiovascular Risk Assessment and Management Making a Difference
Cardiovascular Risk Assessment and Management Making a Difference Norman Sharpe March 2014 Numbers and age-standardised mortality rates from all causes, by sex, 1950 2010 Death rates halved Life expectancy
More informationCost-effectiveness of brief intervention and referral for smoking cessation
Cost-effectiveness of brief intervention and referral for smoking cessation Revised Draft 20 th January 2006. Steve Parrott Christine Godfrey Paul Kind Centre for Health Economics on behalf of PHRC 1 Contents
More informationPersonal statement on Continuous Subcutaneous Insulin Infusion Professor John Pickup
1 Personal statement on Continuous Subcutaneous Insulin Infusion Professor John Pickup King s College London School of Medicine, Guy s Hospital, London SE1 9RT Experience of the technology I am the lead
More informationNHS DIABETES PREVENTION PROGRAMME: Preventing Type 2 Diabetes in England
NHS DIABETES PREVENTION PROGRAMME: Preventing Type 2 Diabetes in England WHO WE ARE Public Health England (PHE) is an executive agency of the Department of Health. We protect and improve the nation's health
More informationBritish Dietetic Association-Dietetics Today. Glasgow & Clyde Weight Management Service
British Dietetic Association-Dietetics Today Glasgow & Clyde Weight Management Service Dr Marie L Prince Chartered Clinical Psychologist Contact: marie.prince@ggc.scot.nhs.uk GCWMS Ward 23 Surgical Block
More informationType 2 diabetes in adults: controlling your blood glucose by taking a second medicine what are your options?
Patient decision aid Type 2 diabetes in adults: controlling your blood glucose by taking a second medicine what are your options? nice.org.uk/guidance/ng28 Published: December 2015 About this decision
More informationThe Effects of Orlistat Treatment Interruption on Weight and Associated Metabolic Parameters
394) Prague Medical Report / Vol. 107 (2006) No. 4, p. 394 400 The Effects of Orlistat Treatment Interruption on Weight and Associated Metabolic Parameters Owen K., Svačina S. Third Medical Department
More informationSection 5: Management of obesity 2 (continued)
Section 5: Management of obesity 2 (continued) Sibutramine (Reductil): marketing authorisation suspended On 21 January 2010, the MHRA announced the suspension of the marketing authorisation for the obesity
More informationInsulin Titration- Group Education
Insulin Titration- Group Education Improving your blood glucose control through self-titration of insulin Introduction Evidence shows improvement in glycaemic control reduces risk of long term complications
More informationChloe Thomas, Susi Sadler, Penny Breeze, Hazel Squires, Michael Gillett, Alan Brennan
To cite: Thomas C, Sadler S, Breeze P, et al. Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation.
More informationFructose in diabetes: Friend or Foe. Kim Chong Hwa MD,PhD Sejong general hospital, Division of Endocrinology & Metabolism
Fructose in diabetes: Friend or Foe Kim Chong Hwa MD,PhD Sejong general hospital, Division of Endocrinology & Metabolism Contents What is Fructose? Why is Fructose of Concern? Effects of Fructose on glycemic
More informationNew York State Medicaid Prescriber Education Program
New York State Medicaid Prescriber Education Program Metformin as a first-line medication Treating type 2 diabetes mellitus Key messages 1) Metformin should be used as a first-line medication in almost
More informationPreventing Diabetes K A R O L E. W A T S O N, M D, P H D, F A C C P R O F E S S O R O F M E D I C I N E / C A R D I O L O G Y
Preventing Diabetes 2018 K A R O L E. W A T S O N, M D, P H D, F A C C P R O F E S S O R O F M E D I C I N E / C A R D I O L O G Y D A V I D G E F F E N S C H O O L O F M E D I C I N E A T U C L A CO-DIRECTOR,
More informationHEALTH TARGETS IN PRIMARY CARE
HEALTH TARGETS IN PRIMARY CARE MORE HEART AND DIABETES CHECKS BETTER HELP FOR SMOKERS TO QUIT Better Help for Smokers to Quit 90% of enrolled patients who smoke and are seen by General Practice, will be
More informationPage: 1 / 5 Produced by the Centre for Reviews and Dissemination Copyright 2018 University of York
Weight management using a meal replacement strategy: meta and pooling analysis from six studies Heymsfield S B, van Mierlo C A, van der Knaap H C, Heo M, Frier H I CRD summary The review assessed partial
More informationTreating Type 2 Diabetes by Treating Obesity. Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition
Treating Type 2 Diabetes by Treating Obesity Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition 2 Center Stage Obesity is currently an epidemic in the United States, with
More informationHEALTH PROMOTION SERVICE QUARTERLY REPORT (Q3) PROJECT TITLE: Workplace Health. Action Plan to address any variance
HEALTH PROMOTION SERVICE QUARTERLY REPORT (Q3) PROJECT TITLE: Workplace Health Oct Dec 11 (Q3) Outcomes and behavioural goals planned Continue to raise awareness of the benefits of healthier workplaces
More information